NCT00782652View on ClinicalTrials.gov

The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Right Ventricular Infarction
Interventions
DRUG

inhaled nitric oxide

Continuous delivery at either 40 or 80 ppm for a duration of up to 14 days

DRUG

nitrogen gas

Continuous delivery at either 40 or 80 ppm for a duration of up to 14 days

Trial Locations (6)

42

Institute of Cardiology Warsaw, Alpejska

48073

William Beaumont Hospital, Royal Oak

02114

Massachusetts General Hospital, Boston

B-3000

University Hospital Gasthuisberg, University of Leuven, Leuven

K1Y 4W7

Univeristy of Ottawa Heart Institute, Ottawa

08036

Cardiovascular Department, Hospital Clinic, Barcelona

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT00782652 - The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients | Biotech Hunter | Biotech Hunter